Leidos is trading at $127.72 (+4.97%) in pre-market, with no clear catalyst confirmed.

  • An October 12 report said Leidos selected X-Bow Systems to develop and produce booster motors for the U.S. Army’s Low-Cost Containerized Munition program; it does not establish that the announcement caused the move.
  • JPMorgan’s October 8 downgrade to Neutral from Overweight cited Health-segment margin concerns, but does not explain the upward move.
  • Pre-market volume or trading activity data was unavailable in the sources reviewed.